Pfizer and Shanghai Pharmaceutical sign memorandum of understanding for potential strategic partnership
20 April 2011 | By Pfizer
Shanghai Pharmaceutical Co. Ltd. and Pfizer Inc. today announced the signing of a MOU...
List view / Grid view
News
Gilead and MicroDose Therapeutx announce license and collaboration agreement to develop MDT-637
20 April 2011 | By Gilead Sciences
Gilead & MicroDose Therapeutx have entered into an exclusive worldwide license...
FDA approves Roche’s HPV test for identifying women at highest risk for cervical cancer
20 April 2011 | By Roche
Roche announced that the FDA has approved the cobas HPV (Human Papillomavirus) Test...
Miles D. White elected to the American Academy of Arts & Sciences
19 April 2011 | By Abbott
Abbott announced that Miles D. White has been elected to the American Academy of Arts and Sciences...
FDA approves Rituxan plus a steroid for use in severe forms of vasculitis
19 April 2011 | By Biogen Idec
Genentech, and Biogen Idec announced today that the FDA approved Rituxan® (rituximab)...
Market leaders Expo Technologies, Umetrics provide better PAT tool connectivity
18 April 2011 | By Expo Technologies LLC
Expo Technologies and Umetrics Inc. announce the release of Expo’s NovaMath 5.0...
Analytik launch PHARMA•ID
18 April 2011 | By analytikLtd
Analytik release PHARMA•IDTM throughout Europe, the smallest, lightest, most cost-effective solution for rapid non-destructive raw material identification...
Aesica in Sunday Times PwC Profit Track 100
18 April 2011 | By Velvet Communications
Aesica Pharmaceuticals was named the 51st most profitable British company in the Sunday Times PwC Profit Track 100...
TTP LabTech partner with leading crystallographer
15 April 2011 | By Alto Marketing Limited
At the SBS conference, TTP LabTech announced collaboration with a world leader in membrane protein crystallography...
Pfizer announces top-line results of third phase 3 clinical trial of Tofacitinib (CP-690,550)
15 April 2011 | By Pfizer
Pfizer Inc. announced top-line results from the ORAL Scan Phase 3 study (A3921044)...
Merck and Johnson & Johnson reach agreement on distribution rights for REMICADE® and SIMPONI®
15 April 2011 | By Merck
Merck and Johnson & Johnson and its subsidiary Centocor Ortho Biotech Inc., announced that the companies have reached an agreement...
Merck commences tender offer for all outstanding shares of Inspire Pharmaceuticals, Inc.
15 April 2011 | By Merck
Merck announced the commencement of the tender offer for all outstanding shares of Inspire Pharmaceuticals, Inc. for $5.00 per share...
ERT awarded over $10m of ePRO business from major pharma companies
14 April 2011 | By The Scott Partnership
ERT has been awarded three new contracts with top tier pharmaceutical companies, totaling over $10m...
Novartis drug Afinitor® recommended by FDA oncology advisory committee
12 April 2011 | By Novartis
Novartis announced that the FDA Oncologic Drugs Advisory Committee recommended approval of Afinitor® (everolimus) tablets...
Novozymes Biopharma to present latest advances in cell culture technology at ESACT
12 April 2011 | By The Scott Partnership
Novozymes Biopharma, will present two scientific posters at the 2011 ESACT meeting...
